Viewing stories from February, 2013
Starpharma Interim Report and Half-year Financial Results
Starpharma today released its interim report and financial results for the half-year ended 31 December 2012.
Financial Highlights
- Reported loss $1.8M (Dec 2011: $4.7 million)
- R&D tax incentives of $6.8M reported in the half-year
- Cash position at 31 December 2012 $33.2M
- R&D tax incentive receivables at 31 December 2012 $8.1M